A cardiovascular risk factor reduction clinic

T W Wilson1, D W Quest, M Wilson

  • 1University of Saskatchewan, Saskatoon, Canada. wilsont@duke.usask.ca

Insights

A cardiovascular risk factor reduction unit (CRFRU) is feasible and effectively reduces coronary artery disease (CAD) risk in high-risk patients. Improvements were seen in blood pressure, lipid profiles, and weight loss after one year.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality globally.
  • Early identification and management of cardiovascular risk factors are crucial for prevention.
  • Specialized units can provide focused interventions for high-risk populations.

Purpose of the Study:

  • To describe the characteristics of patients referred to a cardiovascular risk factor reduction unit (CRFRU).
  • To evaluate the feasibility and effectiveness of a CRFRU in reducing coronary artery disease (CAD) risk.
  • To compare the risk profile of referred patients with the general population.

Main Methods:

  • Prospective cohort study of 704 outpatients with cardiovascular risk factors.
  • Assessment of CAD probability using the Framingham equation.
  • Interventions included lifestyle advice and pharmacotherapy.
  • Follow-up reassessment after one year for 388 patients.

Main Results:

  • Referred patients exhibited significantly higher CAD risk compared to the general population.
  • A considerable proportion of patients achieved a reduced risk score after one year.
  • Improvements were associated with favorable changes in systolic blood pressure, lipid profiles, and weight loss.

Conclusions:

  • A CRFRU is a feasible model for cardiovascular risk management.
  • The unit demonstrated effectiveness in reducing CAD risk in a significant patient cohort.
  • Targeted interventions can lead to measurable improvements in modifiable risk factors.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...